Venous Thromboembolism (VTE) Prophylaxis With REGN7508 and REGN9933 in Adult and Adolescent Participants With a Peripherally Inserted Central Catheter (PICC)

NCT07697599 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

1908

Enrollment

INDUSTRY

Sponsor class

Conditions

Venous Thromboembolism (VTE)

Interventions

DRUG: REGN7508
DRUG: REGN9933
DRUG: Placebo

Sponsor

Regeneron Pharmaceuticals